EP08.01-03 Lymphocyte Count Pre-immunotherapy Predicts Progression-Free Survival in Stage III NSCLC Treated with Chemoradiotherapy and Immunotherapy

Ashley Horne

Research output: Chapter in Book/Conference proceedingConference contributionpeer-review

Abstract

DOI:10.1016/j.jtho.2023.09.1064
Original languageEnglish
Title of host publicationJournal of Thoracic Oncology
Publication statusPublished - 2023

Fingerprint

Dive into the research topics of 'EP08.01-03 Lymphocyte Count Pre-immunotherapy Predicts Progression-Free Survival in Stage III NSCLC Treated with Chemoradiotherapy and Immunotherapy'. Together they form a unique fingerprint.

Cite this